The Boston Beer Company, Inc. (NYSE:SAM – Get Free Report) has earned an average rating of “Hold” from the fourteen brokerages that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $335.21.
Several research analysts recently weighed in on SAM shares. UBS Group dropped their price target on Boston Beer from $390.00 to $355.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 28th. Roth Mkm boosted their target price on Boston Beer from $406.00 to $422.00 and gave the company a “buy” rating in a research note on Tuesday, January 23rd. Sanford C. Bernstein upgraded Boston Beer from an “underperform” rating to a “market perform” rating and boosted their target price for the company from $280.00 to $335.00 in a research note on Tuesday, January 16th. Morgan Stanley lowered their target price on Boston Beer from $285.00 to $275.00 and set an “underweight” rating on the stock in a research note on Wednesday, February 28th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $337.00 target price on shares of Boston Beer in a research note on Wednesday, February 28th.
Check Out Our Latest Research Report on SAM
Insider Buying and Selling
Institutional Investors Weigh In On Boston Beer
Several hedge funds and other institutional investors have recently made changes to their positions in SAM. CWM LLC increased its stake in shares of Boston Beer by 264.2% in the 3rd quarter. CWM LLC now owns 193 shares of the company’s stock valued at $75,000 after buying an additional 140 shares during the period. HGK Asset Management Inc. grew its stake in shares of Boston Beer by 19.3% during the third quarter. HGK Asset Management Inc. now owns 1,597 shares of the company’s stock worth $622,000 after purchasing an additional 258 shares during the period. Mission Wealth Management LP acquired a new stake in shares of Boston Beer during the third quarter worth $227,000. Dakota Wealth Management acquired a new stake in shares of Boston Beer during the third quarter worth $273,000. Finally, Stratos Wealth Partners LTD. acquired a new stake in shares of Boston Beer during the third quarter worth $348,000. 81.13% of the stock is owned by institutional investors and hedge funds.
Boston Beer Trading Down 2.5 %
NYSE:SAM opened at $278.41 on Friday. The firm has a market capitalization of $3.35 billion, a price-to-earnings ratio of 34.93, a PEG ratio of 1.16 and a beta of 1.02. Boston Beer has a 1-year low of $274.78 and a 1-year high of $395.52. The business’s fifty day moving average price is $302.38 and its 200 day moving average price is $332.89.
Boston Beer (NYSE:SAM – Get Free Report) last posted its quarterly earnings results on Thursday, April 25th. The company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.96. The firm had revenue of $426.05 million for the quarter, compared to analyst estimates of $414.18 million. Boston Beer had a return on equity of 10.11% and a net margin of 4.60%. Equities analysts forecast that Boston Beer will post 9.91 earnings per share for the current year.
Boston Beer Company Profile
The Boston Beer Company, Inc produces and sells alcohol beverages primarily in the United States. The company's flagship beer is Samuel Adams Boston Lager. It offers various beers, hard ciders, flavored malt beverages, and hard seltzers under the Samuel Adams, Twisted Tea, Truly, Angry Orchard, Dogfish Head, Angel City, and Coney Island brand names.
See Also
- Five stocks we like better than Boston Beer
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Pros And Cons Of Monthly Dividend Stocks
- Hilton Demonstrates Asset Light is Right for Investors
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Boston Beer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Beer and related companies with MarketBeat.com's FREE daily email newsletter.